Literature DB >> 1722127

Palliation of malignant dysphagia with laser therapy: predictability of results.

R C Mason1, N Bright, I McColl.   

Abstract

This study reports the results of 189 patients treated by laser therapy for malignant dysphagia. Ninety-one per cent of patients derived benefit from treatment, but the long-term survival rate was poor, with only 12 per cent of patients surviving for 6 months. Survival was not influenced by either tumour length, site or histological type. Patients with adenocarcinomas initially showed improved swallowing after laser treatment compared with those with squamous tumours, but this difference had disappeared by 2 months. The results of laser treatment were not influenced by either tumour length or site.

Entities:  

Mesh:

Year:  1991        PMID: 1722127     DOI: 10.1002/bjs.1800781125

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  4 in total

1.  Insertion of self-expanding metal stents for malignant dysphagia: assessment of a simple endoscopic method.

Authors:  R Singhvi; F Abbasakoor; J M Manson
Journal:  Ann R Coll Surg Engl       Date:  2000-07       Impact factor: 1.891

2.  Endoscopic palliative treatment for esophageal and gastric cancer: techniques, complications, and survival in a population-based cohort of 948 patients.

Authors:  A M Thompson; T Rapson; F J Gilbert; K G M Park
Journal:  Surg Endosc       Date:  2004-05-28       Impact factor: 4.584

3.  Palliation of malignant dysphagia: an alternative to surgery.

Authors:  R Mason
Journal:  Ann R Coll Surg Engl       Date:  1996-09       Impact factor: 1.891

4.  A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma.

Authors:  T Sabharwal; M S Hamady; S Chui; S Atkinson; R Mason; A Adam
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.